scholarly article | Q13442814 |
P356 | DOI | 10.1097/00006123-199608000-00001 |
P698 | PubMed publication ID | 8832660 |
P2093 | author name string | Giese A | |
Westphal M | |||
P2860 | cites work | Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme | Q55489464 |
Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity | Q24651389 | ||
Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation | Q28187857 | ||
CD44 is the principal cell surface receptor for hyaluronate | Q28261336 | ||
Integrins: a family of cell surface receptors | Q28288125 | ||
Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system | Q28292445 | ||
Purification and characterization of integrin alpha 9 beta 1 | Q28575956 | ||
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells | Q28578219 | ||
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin | Q30195270 | ||
Cytoskeleton--plasma membrane interactions | Q34261958 | ||
The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice | Q34539752 | ||
Molecular and cellular characterization of the glial roof plate of the spinal cord and optic tectum: a possible role for a proteoglycan in the development of an axon barrier | Q34556986 | ||
Molecular cloning and primary structure of myelin-associated glycoprotein | Q34590781 | ||
Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1 | Q36080037 | ||
Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading | Q36218407 | ||
A fibronectin-like molecule is present in the developing cat cerebral cortex and is correlated with subplate neurons | Q36218682 | ||
Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease | Q36220992 | ||
Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes | Q36222577 | ||
Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules | Q36232422 | ||
Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin | Q36234780 | ||
Control of intracellular pH and growth by fibronectin in capillary endothelial cells | Q36383431 | ||
Multiple elevations of cytosolic-free Ca2+ in human neutrophils: initiation by adherence receptors of the integrin family | Q36529394 | ||
A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion | Q36530864 | ||
CD44H regulates tumor cell migration on hyaluronate-coated substrate | Q36531720 | ||
Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its immunoglobulin-like domains | Q36531957 | ||
Phosphorylation of the fibronectin receptor complex in cells transformed by oncogenes that encode tyrosine kinases | Q37397390 | ||
Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin alpha 5 beta 1, independent of cell shape | Q37588910 | ||
Proteoglycans as modulators of growth factor activities | Q37656847 | ||
Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme | Q37870259 | ||
Unwrapping the genes of myelin | Q38211942 | ||
Intratumoral histologic heterogeneity of gliomas. A quantitative study | Q38882699 | ||
Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro | Q39101918 | ||
The fallacy of the localized supratentorial malignant glioma | Q39244859 | ||
The extracellular matrix of the central and peripheral nervous systems: structure and function | Q39652117 | ||
The role of the subependymal plate in glial tumorigenesis | Q40103298 | ||
Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature | Q40280435 | ||
Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. | Q40396971 | ||
Extracellular matrix-degrading proteinases in the nervous system | Q40689757 | ||
Four patterns of laminin-immunoreactive structure in developing rat brain | Q41183739 | ||
Substrates for astrocytoma invasion | Q41322756 | ||
Assessment of brain tumor cell motility in vivo and in vitro | Q41352261 | ||
Laminin is produced by early rat astrocytes in primary culture | Q41406978 | ||
Migration of genetically labeled glioma cells after implantation into murine brain | Q41459068 | ||
Immunohistochemical localisation of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas | Q41486358 | ||
Protein kinase C alpha, delta, epsilon and zeta in C6 glioma cells. TPA induces translocation and down-regulation of conventional and new PKC isoforms but not atypical PKC zeta | Q41521135 | ||
Myelin-associated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuron-oligodendrocyte and oligodendrocyte-oligodendrocyte interaction | Q41526296 | ||
Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen | Q41528688 | ||
Ras-Transformed Cells Express Both CD44 and RHAMM Hyaluronan Receptors: Only RHAMM Is Essential for Hyaluronan-Promoted Locomotion | Q41540302 | ||
Tenascin mediates cell attachment through an RGD-dependent receptor | Q41566069 | ||
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model | Q41586807 | ||
Mechanisms of C6 glioma cell and fetal astrocyte migration into hydrated collagen I gels | Q41620201 | ||
The role of protein kinase C in migration of rat glioma cells from spheroid cultures. | Q41628749 | ||
Expression of multiple integrins and extracellular matrix components by C6 glioma cells | Q41636034 | ||
Isolation and characterization of a metalloproteinase secreted by rat glioma cells in serum-free culture | Q41717593 | ||
Astrocytes secrete basal lamina after hemisection of rat spinal cord | Q42435282 | ||
Brain-specific hyaluronate-binding protein. A product of white matter astrocytes? | Q42487411 | ||
Human malignant astrocytoma xenografts migrate in rat brain: a model for central nervous system cancer research | Q42496833 | ||
Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies | Q42811321 | ||
Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies | Q43513464 | ||
Inhibition of neural crest cell migration by aggregating chondroitin sulfate proteoglycans is mediated by their hyaluronan-binding region | Q43521586 | ||
Prognostic implications of the bromodeoxyuridine labeling index of human gliomas | Q43998427 | ||
Domains of neuronal heparan sulphate proteoglycans involved in neurite growth on laminin | Q44432138 | ||
Biological significance of tissue plasminogen activator content in brain tumors | Q46827337 | ||
Immunohistochemical investigation of collagen subtypes in human glioblastomas | Q48152362 | ||
Basement membrane invasion of glioma cells mediated by integrin receptors | Q48164504 | ||
Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome | Q48214278 | ||
The proteoglycan chondroitin sulfate is present in a subpopulation of cultured astrocytes and in their precursors | Q48215986 | ||
Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells | Q48382846 | ||
Migration of fresh human malignant astrocytoma cells into hydrated gel wafers in vitro | Q48388520 | ||
Matrix degrading metalloproteinases | Q48388549 | ||
Glycosaminoglycan changes in human gliomas. A biochemical study | Q48398534 | ||
The migration of substances in the neuronal microenvironment | Q48408786 | ||
The subependymal plate and the genesis of gliomas | Q48436571 | ||
Differential expression of the CD44 molecule in human brain tumours | Q48526944 | ||
A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody | Q48630477 | ||
The risks of metastases from shunting in children with primary central nervous system tumors | Q48710889 | ||
Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro | Q48752343 | ||
Immature type-1 astrocytes suppress glial scar formation, are motile and interact with blood vessels | Q48770214 | ||
The Incidence of Interhemispheric Extension of Glioblastoma Multiforme through the Corpus Callosum | Q51373525 | ||
Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. | Q52272634 | ||
Specific attachment and migration of human astrocytoma cells on human but not murine laminin. | Q55481386 | ||
Glioblastoma cells do not intravasate into blood vessels. | Q55481414 | ||
The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. | Q55481603 | ||
Collagens, integrins and the mesenchymal drift in glioblastomas: A comparison of biopsy specimens, spheroid and early monolayer cultures | Q55481758 | ||
CD44 plays a role in adhesive interactions between glioma cells and extracellular matrix components. | Q55481890 | ||
Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. | Q55486347 | ||
Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. | Q55486986 | ||
Products of cells cultured from gliomas. IV. Extracellular matrix proteins of gliomas. | Q55487650 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 235-50; discussion 250-2 | |
P577 | publication date | 1996-08-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Neurosurgery | Q7002693 |
P1476 | title | Glioma invasion in the central nervous system | |
P478 | volume | 39 |
Q33997839 | "...those left behind." Biology and oncology of invasive glioma cells |
Q88945550 | A 3D topographical model of parenchymal infiltration and perivascular invasion in glioblastoma |
Q33565884 | A Numerical Handling of the Boundary Conditions Imposed by the Skull on an Inhomogeneous Diffusion-Reaction Model of Glioblastoma Invasion Into the Brain: Clinical Validation Aspects |
Q38401094 | A Patient-Specific Anisotropic Diffusion Model for Brain Tumour Spread. |
Q35162374 | A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma |
Q36115903 | A metalloprotease activity from C6 glioma cells inactivates the myelin-associated neurite growth inhibitors and can be neutralized by antibodies |
Q44496375 | A novel concept of glomeruloid body formation in experimental cerebral metastases |
Q61810658 | A novel radiological classification system for cerebral gliomas: The Brain-Grid |
Q37696664 | A role for ion channels in perivascular glioma invasion |
Q39661349 | A specific isoform of glial cell line‐derived neurotrophic factor family receptor alpha 1 regulates RhoA expression and glioma cell migration |
Q36952294 | Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. |
Q42496307 | Adhesive and invasive features in gliomas |
Q37384592 | Aligned chitosan-polycaprolactone polyblend nanofibers promote the migration of glioblastoma cells |
Q55474171 | Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. |
Q39129351 | Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells |
Q41071260 | Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor |
Q90207133 | An Open-Source Tool for Anisotropic Radiation Therapy Planning in Neuro-oncology Using DW-MRI Tractography |
Q33854863 | An image-driven parameter estimation problem for a reaction-diffusion glioma growth model with mass effects |
Q40490472 | Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway |
Q50770980 | Angiotropism of human prostate cancer cells: implications for extravascular migratory metastasis |
Q37736273 | Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma |
Q40980125 | Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential |
Q34439167 | Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas |
Q40069336 | Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion. |
Q48318360 | BCL-2 promotes migration and invasiveness of human glioma cells |
Q48352697 | BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility |
Q39659810 | Beta1,4-galactosyltransferase V A growth regulator in glioma. |
Q38790816 | Biomaterial-Based Implantable Devices for Cancer Therapy |
Q38779205 | Biophysical modeling of brain tumor progression: From unconditionally stable explicit time integration to an inverse problem with parabolic PDE constraints for model calibration. |
Q48611608 | Boron neutron capture therapy: preliminary study of BNCT with sodium borocaptate (Na2B1 2H1 1SH) on glioblastoma |
Q37727823 | Bringing the heavy: carbon ion therapy in the radiobiological and clinical context |
Q28344466 | Bromelain Reversibly Inhibits Invasive Properties of Glioma Cells |
Q35742619 | Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment. |
Q89506448 | Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells |
Q30982349 | Cerebral edema associated with Gliadel wafers: two case studies |
Q55463899 | Cerebral high grade glioma with crossed cerebellar metastases. A report of three cases. |
Q30450267 | Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates |
Q28216166 | Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2 |
Q40226442 | Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat. |
Q44135421 | Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid |
Q36813096 | Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells. |
Q33518926 | Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme |
Q24799123 | Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas |
Q34158558 | Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta |
Q45372198 | Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme |
Q35107972 | Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment |
Q64075444 | Cx43-Associated Secretome and Interactome Reveal Synergistic Mechanisms for Glioma Migration and MMP3 Activation |
Q33287677 | Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data |
Q39042500 | Definition of K(trans) and FA thresholds for better assessment of experimental glioma using high-field MRI: a feasibility study |
Q39975221 | Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. |
Q84348303 | Desmoplastic tumour-associated stroma versus neural tissue in central nervous system metastasis: effects of different microenvironments on tumour growth |
Q36931690 | Diffuse glioma growth: a guerilla war |
Q83815844 | Diffusion MR Imaging: An Important Tool in the Assessment of Brain Tumors |
Q30358803 | Direct Cranial Nerve Involvement by Gliomas: Case Series and Review of the Literature. |
Q35756665 | Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. |
Q40360371 | Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. |
Q97543194 | Dissecting and rebuilding the glioblastoma microenvironment with engineered materials |
Q55476454 | Dissecting glioma invasion: interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype. |
Q41667528 | Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth |
Q39481186 | Down‐regulation of connexin43 expression reveals the involvement of caveolin‐1 containing lipid rafts in human U251 glioblastoma cell invasion |
Q48335213 | ECM-mediated glioma cell invasion |
Q38815883 | EFEMP2 is upregulated in gliomas and promotes glioma cell proliferation and invasion |
Q35145144 | EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma |
Q50855585 | Effective equations for anisotropic glioma spread with proliferation: a multiscale approach and comparisons with previous settings |
Q40893469 | Effects of radiation on a model of malignant glioma invasion |
Q55476453 | Effects of radiation on a three-dimensional model of malignant glioma invasion. |
Q38732499 | Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification |
Q35914897 | Emerging insights into the molecular and cellular basis of glioblastoma |
Q92948777 | Endothelial cells promote 3D invasion of GBM by IL-8-dependent induction of cancer stem cell properties |
Q38244936 | Engineering strategies to mimic the glioblastoma microenvironment |
Q45983482 | Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma. |
Q82759521 | Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion |
Q90193121 | Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells |
Q42048997 | Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors |
Q42480671 | Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions |
Q55475249 | Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. |
Q55475897 | Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate. |
Q48514718 | Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns |
Q28263549 | Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion |
Q24649857 | Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas |
Q51489436 | Gene expressions of TRP channels in glioblastoma multiforme and relation with survival |
Q34331925 | Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican |
Q30620741 | Glioblastoma behaviors in three-dimensional collagen-hyaluronan composite hydrogels. |
Q38065976 | Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies |
Q36015831 | Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype |
Q55475300 | Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. |
Q55476463 | Glioma cell migration is associated with glioma-induced angiogenesis in vivo. |
Q46568772 | Glioma dissemination along the corticospinal tract. |
Q38418828 | Glioma follow white matter tracts: a multiscale DTI-based model |
Q48177774 | Glioma invasion — Pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1 |
Q40295178 | Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. |
Q49112647 | Gliomas of the posterior fossa in adults. |
Q24812016 | Glycosaminoglycans modulate C6 glioma cell adhesion to extracellular matrix components and alter cell proliferation and cell migration |
Q30661008 | Group sparse canonical correlation analysis for genomic data integration |
Q33989023 | Growth factor receptor tyrosine kinases: cell adhesion kinase family suggests a novel signaling mechanism in cancer |
Q26821781 | Heparin in malignant glioma: review of preclinical studies and clinical results |
Q55470753 | High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. |
Q28206393 | Hyaluronate receptors mediating glioma cell migration and proliferation |
Q90290820 | Identification of Grade-associated MicroRNAs in Brainstem Gliomas Based on Microarray Data |
Q36254216 | Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells |
Q47107562 | Identification of potential therapeutic targets for gliomas by bioinformatics analysis |
Q48921848 | Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding |
Q41829334 | Image-driven modeling of the proliferation and necrosis of glioblastoma multiforme. |
Q34203946 | Imaging biomarkers of brain tumour margin and tumour invasion |
Q30892642 | Imaging of brain tumors with diffusion-weighted and diffusion tensor MR imaging |
Q33426397 | Imaging of human brain tumor tissue by near-infrared laser coherence tomography |
Q55478230 | Implantation of C6 astrocytoma spheroid into collagen type I gels: invasive, proliferative, and enzymatic characterizations |
Q47985889 | In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators |
Q45035648 | In-silico oncology: an approximate model of brain tumor mass effect based on directly manipulated free form deformation |
Q48602671 | Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma |
Q39958338 | Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells |
Q40531063 | Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. |
Q41962476 | Influence of chondroitin sulfate and hyaluronic acid on structure, mechanical properties, and glioma invasion of collagen I gels |
Q42475272 | Inhibition of Necl-5 (CD155/PVR) reduces glioblastoma dispersal and decreases MMP-2 expression and activity |
Q40440231 | Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study |
Q41046634 | Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor |
Q48687445 | Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo |
Q40968600 | Inhibition of phospholipase C-gamma1 activation blocks glioma cell motility and invasion of fetal rat brain aggregates |
Q33959036 | Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion |
Q35110943 | Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2. |
Q35607459 | Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma. |
Q30275623 | Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms. |
Q34029050 | Interstitial guidance of cancer invasion |
Q38549080 | Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats |
Q33995771 | Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation |
Q38124653 | Invasion as target for therapy of glioblastoma multiforme |
Q33918861 | Invasive glioblastoma cells acquire stemness and increased Akt activation. |
Q31133294 | Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging |
Q35064477 | Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration. |
Q39550861 | Knockdown of TFPI-2 promotes migration and invasion of glioma cells |
Q36375193 | Knockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cells |
Q42480247 | Laminin expression by glial fibrillary acidic protein positive cells in human gliomas |
Q42037952 | Late onset leptomeningeal and whole spine metastasis from supratentorial Glioblastoma multiforme: An uncommon manifestation of a common tumor |
Q30563306 | Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease |
Q40912142 | Local spread of malignant neuroepithelial tumors |
Q37693612 | Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression |
Q39189725 | Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-α-induced human renal carcinoma cell invasion |
Q33941052 | MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells |
Q36542070 | MMP-9 and uPAR regulated glioma cell migration |
Q33640030 | MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice |
Q27021470 | Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma |
Q35553146 | Mechanisms of glioma cell invasion |
Q34444283 | Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion |
Q89866258 | Meningeal lymphatic vessels regulate brain tumor drainage and immunity |
Q57492335 | Microenvironmental Rigidity of 3D Scaffolds and Influence on Glioblastoma Cells: A Biomaterial Design Perspective |
Q48393459 | Microfabricated mimics of in vivo structural cues for the study of guided tumor cell migration |
Q39268476 | Micropatterned Thermoresponsive Surfaces by Polymerization of Monomer Crystals: Modulating Cellular Morphology and Cell–Substrate Interactions |
Q48475053 | Microscopic DTI accurately identifies early glioma cell migration: correlation with multimodal imaging in a new glioma stem cell model |
Q37348475 | Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting. |
Q55479968 | Migration of human glioma cells in response to tumour cyst fluids. |
Q74418569 | Migration pathways of human glioblastoma cells xenografted into the immunosuppressed rat brain |
Q40771292 | Migratory activity of human glioma cell lines in vitro assessed by continuous single cell observation |
Q30582618 | Mimicking white matter tract topography using core-shell electrospun nanofibers to examine migration of malignant brain tumors. |
Q58921888 | Modeling a Tumor Growth with Piecewise Constant Arguments |
Q35900778 | Molecular Physiology of SPAK and OSR1: Two Ste20-Related Protein Kinases Regulating Ion Transport |
Q34480160 | Molecular biology of nervous system tumors |
Q34117390 | Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers |
Q35641225 | Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis |
Q35918449 | Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 3: brain tumor invasiveness |
Q36528894 | Molecular pathways triggering glioma cell invasion |
Q34108050 | Multi-agent cytostatic treatment of 'low-grade' gliomas |
Q28572144 | Mutations in isocitrate dehydrogenase 2 accelerate glioma cell migration via matrix metalloproteinase-2 and 9 |
Q64971917 | Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner. |
Q37316856 | N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy |
Q40364296 | Neural stem cell migration toward gliomas in vitro |
Q35016216 | Neuronal migration and molecular conservation with leukocyte chemotaxis |
Q34108038 | Neurosurgical advances in the treatment of brain tumors |
Q34090967 | Novel chemotherapeutic agents for the treatment of brain cancer |
Q39126167 | O-Linked Mannose β-1,2-N-acetylglucosaminyltransferase 1 Correlated With the Malignancy in Glioma |
Q34581669 | Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study |
Q92438443 | On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data |
Q49015812 | Paclitaxel delivery to brain tumors from hydrogels: A computational study |
Q41660335 | Pattern of recurrence and factors associated with cerebrospinal fluid dissemination of glioblastoma in Chinese patients. |
Q44796290 | Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma |
Q48882899 | Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model |
Q55456996 | Patterns of Invasive Growth in Malignant Gliomas-The Hippocampus Emerges as an Invasion-Spared Brain Region. |
Q35097373 | Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis |
Q92421251 | Pericytes in Sarcomas and Other Mesenchymal Tumors |
Q34696172 | Pharmacokinetics of the carmustine implant |
Q27010046 | Polymeric drug delivery for the treatment of glioblastoma |
Q91030930 | Preoperative Diffusion Tensor Imaging: A Landmark Modality for Predicting the Outcome and Characterization of Supratentorial Intra-Axial Brain Tumors |
Q24656634 | Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas |
Q34627812 | Proteases and the biology of glioma invasion |
Q36398251 | Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy |
Q48482286 | Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy |
Q44359580 | Quantitative evaluation of white matter tract DTI parameter changes in gliomas using nonlinear registration |
Q35782888 | Receptor protein tyrosine phosphatase zeta as a therapeutic target for glioblastoma therapy |
Q52571329 | Role of Diffusion Tensor Imaging in Brain Tumor Surgery |
Q41054003 | Role of Extracellular Matrix in Tumor Invasion: Migration of Glioma Cells Along Fibronectin-Positive Mesenchymal Cell Processes |
Q35696322 | Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgery |
Q37079980 | Role of hyaluronan in glioma invasion |
Q38361238 | Role of tenascins in the ECM of gliomas |
Q28214662 | Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility |
Q39445843 | SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells |
Q43804262 | SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins |
Q24290219 | Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells |
Q41991831 | Shift of microRNA profile upon glioma cell migration using patient-derived spheroids and serum-free conditions. |
Q36316397 | Simulating radiotherapy effect in high-grade glioma by using diffusive modeling and brain atlases |
Q34410643 | Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. |
Q48520992 | Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis |
Q101452047 | Spinal drop metastasis of Glioblastoma - Two Case Reports, Clinicopathological features, Current Modalities of Evaluation and Treatment with a Review of literature |
Q30660253 | Spinal leptomeningeal metastasis from cerebral glioblastoma multiforme presenting with radicular pain: case report and literature review |
Q30544130 | Spontaneous migration of cancer cells under conditions of mechanical confinement |
Q52093220 | Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations |
Q38165795 | Systematic review of protein biomarkers of invasive behavior in glioblastoma |
Q55475529 | Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC. |
Q27342759 | Tensile Forces Originating from Cancer Spheroids Facilitate Tumor Invasion |
Q38683271 | The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas |
Q35770218 | The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme |
Q30854400 | The brain slice chamber, a novel variation of the Boyden Chamber Assay, allows time-dependent quantification of glioma invasion into mammalian brain in vitro |
Q55462091 | The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma |
Q24684139 | The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors |
Q39486482 | The intrinsic fusogenicity of glioma cells as a factor of transformation and progression in the tumor microenvironment |
Q36288254 | The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells. |
Q39489252 | The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway |
Q27334481 | The p75 neurotrophin receptor is a central regulator of glioma invasion |
Q41037827 | The role of extracellular matrix in glioma invasion: a cellular Potts model approach |
Q33544245 | The role of integrins in immune-mediated diseases of the nervous system |
Q34444294 | The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis |
Q37884413 | The role of stem cells in tumor targeting and growth suppression of gliomas |
Q38594492 | The roles of CD147 in the progression of gliomas |
Q28299334 | The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression |
Q45875949 | Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma |
Q39323223 | Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma |
Q33426563 | Therapeutic strategies for inhibiting invasion in glioblastoma |
Q38738654 | Time-lapse phenotyping of invasive glioma cells ex vivo reveals subtype-specific movement patterns guided by tumor core signaling |
Q34025911 | Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells |
Q35150426 | Toward an Ising model of cancer and beyond |
Q63459818 | Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments |
Q39117565 | Tumor Cohesion and Glioblastoma Cell Dispersal |
Q31123658 | Unique patterns of diffusion directionality in rat brain tumors revealed by high-resolution diffusion tensor MRI. |
Q35083735 | Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma |
Q40868535 | Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor |
Q30784929 | Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients |
Q41525538 | Vascular Endothelial Growth Factor, Irradiation, and Axitinib Have Diverse Effects on Motility and Proliferation of Glioblastoma Multiforme Cells |
Q40486760 | Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas. |
Q37721244 | White matter: organization and functional relevance |
Q35543284 | With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume |
Q48647829 | alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin |
Q33683216 | αB-Crystallin Is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells |
Search more.